These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 18365395

  • 1. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M, Zhu Y, Wang L, Wang Y, Fu S, Min Z.
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [Abstract] [Full Text] [Related]

  • 2. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M, Watorek E, Smolska D, Patrzałek D, Klinger M.
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [Abstract] [Full Text] [Related]

  • 3. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD.
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H, Robert G, Pasticier G, Bernhard JC, Couzi L, Merville P, Ravaud A, Ballanger P, Ferrière JM, Wallerand H.
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical character of renal transplant recipients with bilateral native upper urinary transitional cell carcinoma].
    Zhang P, Wang Y, Zhang XD, Hu XP, Wang W, Zhang Y, Yin H.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 03; 89(4):248-50. PubMed ID: 19552841
    [Abstract] [Full Text] [Related]

  • 7. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C, Luján Marco S, Bahilo Mateu P, Budía Alba A, Pontones Moreno JL, Jiménez Cruz JF.
    Actas Urol Esp; 2010 Jan 03; 34(1):88-94. PubMed ID: 20223138
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan.
    Chiang YJ, Wang HH, Liu KL, Chu SH, Lee WC.
    Transplant Proc; 2008 Sep 03; 40(7):2397-9. PubMed ID: 18790246
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients.
    Firoozan A, Hosseini Moghaddam SM, Einollahi B, Pour-Reza-Gholi F, Nafar M, Basiri A, Ebrahimi-Rad R.
    Transplant Proc; 2005 Sep 03; 37(7):3061-4. PubMed ID: 16213305
    [Abstract] [Full Text] [Related]

  • 11. Post-kidney transplant surgical complications under new immunosuppressive regimens.
    Burgos FJ, Pascual J, Quicios C, Marcen R, Fernández A, López Fando L, Ortuño J.
    Transplant Proc; 2006 Oct 03; 38(8):2445-7. PubMed ID: 17097962
    [Abstract] [Full Text] [Related]

  • 12. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
    Tsaur I, Karalis A, Probst M, Blaheta RA, Scheuermann EH, Gossmann J, Kachel HG, Hauser IA, Jonas D, Obermüller N.
    Cancer Sci; 2010 Nov 03; 101(11):2430-5. PubMed ID: 20707803
    [Abstract] [Full Text] [Related]

  • 13. [Individual immunosuppressive regime in heart transplantation with high risk].
    Wu XJ, Chen LW, Chen DZ, Huang XS, Cao H.
    Zhonghua Wai Ke Za Zhi; 2008 Jun 01; 46(11):820-2. PubMed ID: 19035214
    [Abstract] [Full Text] [Related]

  • 14. [Cancer after kidney transplantation and immunosuppression].
    Ivanovski N, Popov Z, Kolevski P, Cakalaroski K, Antova Z, Spasovski G, Vlckova-Laskovska M, Zografski G.
    Ann Urol (Paris); 2000 Oct 01; 34(5):336-9. PubMed ID: 11144722
    [Abstract] [Full Text] [Related]

  • 15. [Occurrence, types, and therapies of malignant tumors in recipients of renal transplantation].
    Liu GH, Li HZ, Wang HJ, Mao QZ, Xia M, Xie Y, Xue C, Wang H, Ji ZG.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Jun 01; 31(3):288-91. PubMed ID: 19621511
    [Abstract] [Full Text] [Related]

  • 16. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
    Popov Z, Ivanovski O, Kolevski P, Stankov O, Petrovski D, Cakalaroski K, Ivanovski N.
    Transplant Proc; 2007 Oct 01; 39(8):2589-91. PubMed ID: 17954184
    [Abstract] [Full Text] [Related]

  • 17. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation.
    Manuelli M, De Luca L, Iaria G, Tatangelo P, Sforza D, Perrone L, Bellini MI, Angelico R, Anselmo A, Tisone G.
    Transplant Proc; 2010 May 01; 42(4):1314-6. PubMed ID: 20534289
    [Abstract] [Full Text] [Related]

  • 18. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
    Akbarzadehpasha A, Oliaei F, Asrari MR, Alizadeh-Navaei R.
    Saudi J Kidney Dis Transpl; 2010 Nov 01; 21(6):1044-7. PubMed ID: 21060171
    [Abstract] [Full Text] [Related]

  • 19. Hepatocellular carcinoma in renal transplant recipients.
    Chuang CH, Chien YS, Cheng YT, Chen YT, Hu TH, Hsieh H.
    Transplant Proc; 2008 Sep 01; 40(7):2392-4. PubMed ID: 18790244
    [Abstract] [Full Text] [Related]

  • 20. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports.
    Iaria G, Anselmo A, De Luca L, Manuelli M, Lucchesi C, Tariciotti L, Monaco A, Sforza D, Nigro F, Abruzzese E, Tisone G.
    Transplant Proc; 2007 Sep 01; 39(6):2036-7. PubMed ID: 17692685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.